BNTC Stock Analysis: Buy, Sell, or Hold?
BNTC - Benitec Biopharma Inc. Common Stock
$10.40
-0.18 (-1.70%)
▼
5d:
-10.34%
30d:
-14.61%
90d:
-4.67%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When BNTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BNTC is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BNTC is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BNTC is currently trading at $10.40, which is considered oversold relative to its 30-day fair value range of $11.05 to $12.24.
Technical Outlook: Technically, BNTC is showing sideways momentum. The price is currently testing key support at $10.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BNTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $24.33 (+134.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BNTC is showing sideways momentum. The price is currently testing key support at $10.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BNTC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $24.33 (+134.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.05 -
$12.24
Company Quality Score
46/100
(HOLD)
Options IV Signal
25th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 25th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 134.0% below Wall St target ($24.33)
- WARNING: Recommendation downgraded due to -10.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$11.05 -
$12.24
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.10
(10.6%)
Support & Resistance Levels
Support Level
$10.40
Resistance Level
$12.01
Current Trend
Sideways
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.07
Wall Street Target
$24.33
(+134.0%)
Revenue Growth (YoY)
12.5%
Share & Embed Analysis
Last updated: June 03, 2026 5:08 PM ET
Data refreshes hourly during market hours. Next update: 6:08 PM
Data refreshes hourly during market hours. Next update: 6:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTC showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Suvretta Capital Managem…
BUY
77387 shares
2025-12-29
Suvretta Capital Managem…
BUY
16836 shares
2025-12-26
Suvretta Capital Managem…
BUY
50000 shares
2025-12-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
